id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-3058-0001,FDA,FDA-2026-N-3058,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LOARGYS (pegzilarginase-nbln),Notice,Announcement,2026-04-07T04:00:00Z,2026,4,2026-04-07T04:00:00Z,,2026-04-07T18:06:33Z,2026-06722,0,0,09000064b9256d79